| RSG |
Report |
Adjusted EPS (2026Q2) |
BEAT |
pred ~$1.86 vs. cons $1.83 |
MEDIUM |
| RSG |
Report |
Revenue (2026Q2) |
IN-LINE |
pred ~$4.39B vs. cons $4.356B |
MEDIUM |
| RSG |
Report |
Adjusted EBITDA (2026Q2) |
BEAT |
pred ~$1.405B vs. cons $1.390B |
LOW |
| RSG |
Guide |
Revenue guidance |
BETTER |
guide ~$17.25B vs. cons $17.193B (FY2026) |
MEDIUM |
| RSG |
Guide |
Adjusted EBITDA guidance |
LOWER |
guide ~$5.50B vs. cons $5.526B (FY2026) |
MEDIUM |
| RSG |
Guide |
Adjusted EPS guidance |
LOWER |
guide ~$7.24 vs. cons $7.28 (FY2026) |
MEDIUM |
| RSG |
Guide |
Adjusted free cash flow guidance |
BETTER |
guide ~$2.54B vs. cons $2.525B (FY2026) |
LOW |
| RSG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.8% |
— |
MEDIUM |
| RSG |
Return |
5-day cumulative residual |
-2.7% (FOLLOW-THROUGH) |
An EPS beat is offset by FY2026 adjusted-EPS guidance of ~$7.24 vs. consensus $7.28; after predicted first-half EPS of ~$3.56, the guide implies only ~$3.68 for 2026H2 vs. the pre-report consensus-implied ~$3.75, prompting negative out-period revisions despite the quarterly beat. |
MEDIUM |